Table 6. Muscle protein levels before and after SizeOn maximum performance supplementation and resistance training. Values are means (±SD).
| Variable |
Group |
Day 0 |
Day 43 |
Group (p ≤ .05) |
Test (p ≤ .05) |
Group x Test (p ≤ .05) |
| Total Creatine (µmol·mg–1) |
SIZE |
3.48 (.75) |
4.80 (2.42) *† |
.044 |
.020 |
.279 |
| PCC |
3.12 (.72) |
3.61 (.562) *† |
| Total Protein (µg·mg–1) |
SIZE |
.070 (.024) |
.083 (.039) * |
.230 |
.038 |
.623 |
| PCC |
.089 (.026) |
.096 (.029) * |
| MHC 1 (arbitrary density units) |
SIZE |
1101.7 (391.0) |
1394.1 (419.1) * |
.878 |
.041 |
.873 |
| PCC |
1137.6 (536.6) |
1398.4 (531.6) * |
| MHC 2A (arbitrary density units) |
SIZE |
1084.7 (611.9) |
1336.5 (538.7) * |
.657 |
.029 |
.501 |
| PCC |
1278.5 (484.9) |
1504.7 (342.6) * |
| MHC 2X (arbitrary density units) |
SIZE |
892.9 (521.4) |
836.2 (385.9) |
.884 |
.158 |
.120 |
| PCC |
990.7 (188.3) |
767.0 (199.0) |
* denotes a significant increase at Day 43.† Denotes a significant increase for Group. Both supplement groups underwent significant increases in total creatine levels (p = 0.044). Resistance training increased total protein content (p = 0.038) as well as the protein content of Type I (p = 0.041) and Type IIA (p = 0.029) MHC.Muscle protein levels for the PCC (n = 12) and SIZE (n = 12) groups.
